{ "company_number": "11218653", "name": "Q2 Pharma Limited", "url": "/company/11218653", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2018-02-21", "dissolved_on": null, "sic_codes": [ { "code": "47730", "description": "Dispensing chemist in specialised stores", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/47730" } ], "registered_address": { "id": 268305, "url": "/address/268305", "line1": "51 HUGHENDEN ROAD", "line2": "", "post_town": "HIGH WYCOMBE", "county": "", "country": "ENGLAND", "postcode": "HP13 5HS" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11218653", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-11-30", "last_made_up": "2025-02-28", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/11218653/accounts/2025-02-28", "made_up_date": "2025-02-28", "period_start": "2025-02-28", "period_end": "2025-02-28", "entity_name": "Q2 Pharma Limited", "dormant": false, "average_employees": "0.13", "tangible_fixed_assets": "601485.00", "debtors": "635143.00", "cash_bank_in_hand": "417466.00", "current_assets": "1167859.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "67257.00", "total_assets_less_current_liabilities": "668742.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2026.zip" }, { "url": "/company/11218653/accounts/2024-02-28", "made_up_date": "2024-02-28", "period_start": "2024-02-28", "period_end": "2024-02-28", "entity_name": "Q2 Pharma Limited", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "479931.00", "debtors": "477182.00", "cash_bank_in_hand": "234058.00", "current_assets": "846230.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "52403.00", "total_assets_less_current_liabilities": "532334.00", "net_assets_liabilities": "532334.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2025.zip" }, { "url": "/company/11218653/accounts/2023-02-28", "made_up_date": "2023-02-28", "period_start": "2023-02-28", "period_end": "2023-02-28", "entity_name": "Q2 Pharma Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "85428.00", "debtors": "388054.00", "cash_bank_in_hand": "382704.00", "current_assets": "810258.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "455347.00", "total_assets_less_current_liabilities": "540775.00", "net_assets_liabilities": "490435.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2023.zip" }, { "url": "/company/11218653/accounts/2022-02-28", "made_up_date": "2022-02-28", "period_start": "2022-02-28", "period_end": "2022-02-28", "entity_name": "Q2 Pharma Limited", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "24458.00", "debtors": "257270.00", "cash_bank_in_hand": "373289.00", "current_assets": "668059.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "353426.00", "total_assets_less_current_liabilities": "377884.00", "net_assets_liabilities": "327884.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2022.zip" }, { "url": "/company/11218653/accounts/2021-02-28", "made_up_date": "2021-02-28", "period_start": "2021-02-28", "period_end": "2021-02-28", "entity_name": "Q2 Pharma Limited", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "42295.00", "debtors": "479729.00", "cash_bank_in_hand": "159181.00", "current_assets": "674910.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "281632.00", "total_assets_less_current_liabilities": "323927.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2021.zip" }, { "url": "/company/11218653/accounts/2020-02-29", "made_up_date": "2020-02-29", "period_start": "2020-02-29", "period_end": "2020-02-29", "entity_name": "Q2 Pharma Limited", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "45324.00", "debtors": "380411.00", "cash_bank_in_hand": "60102.00", "current_assets": "479513.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "53072.00", "total_assets_less_current_liabilities": "98396.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2021.zip" }, { "url": "/company/11218653/accounts/2019-02-28", "made_up_date": "2019-02-28", "period_start": "2019-02-28", "period_end": "2019-02-28", "entity_name": "Q2 Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "100.00", "cash_bank_in_hand": null, "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": "100.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2019.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/11218653/filing-history" }, "confirmation_statement": { "next_due": "2027-03-13", "last_made_up": "2026-02-27" }, "officers": [], "psc": [ { "name": "Mr Mohammad Tahir Comran", "kind": "individual-person-with-significant-control", "person_url": "/person/3444940", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent" ], "notified_on": "2018-02-21", "ceased_on": "2022-12-14", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Q2 Group International Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/13999727", "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2022-12-14", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T05:26:26.711035+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }